Single User License
INR 16345
Site License
INR 32690
Corporate User License
INR 49035

Service Tax Additional

select a format
Price

Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Helomics Corporation-Medical Equipment-Deals and Alliances Profile

Helomics Corporation-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME9154D
  • |
  • Pages: 35
  • |
  • November 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Helomics Corporation (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company's products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor response to various chemotherapeutic and biologic agents. Helomics' biospecifx is a biomarker that is used to test drug response and patient prognosis. The company also offers contract research, genefx colon, which is a microarray-based gene signature that identifies patients at risk of recurrence. It serves clinical testing, precision medicine and cancer research needs of physicians. The company has presence in US and Canada. Precision is headquartered in Pittsburgh, Pennsylvania, the US.

Helomics Corporation-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Helomics Corporation , Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Helomics Corporation , Medical Equipment Deals By Type, 2010 to YTD 2016 7

Helomics Corporation , Medical Equipment, Deals By Region, 2010 to YTD 2016 8

Helomics Corporation , Medical Equipment, Deals By Market, 2010 to YTD 2016 9

Helomics Corporation , Medical Equipment, Deals Summary, 2010 to YTD 2016 10

Helomics Corporation , Medical Equipment, Deal Details 11

Venture Financing 11

Precision Therapeutics Raises US$14 Million In Venture Financing 11

Precision Therapeutics Secures US$35 Million In Series D Financing Round 12

Private Equity 14

Healthcare Royalty Invests USD60 Million in Precision Therapeutics 14

Partnerships 15

Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test 15

Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 17

Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics 19

Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 20

Rosetta Genomics Enters Into Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 21

Helomics Corporation -Key Competitors 23

Key Employees 24

Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Strategy And Business Planning 26

Apr 19, 2016: Helomics Announces Second Phase of Realignment Towards a Research and Clinical Products Company in Personalized Healthcare 26

Jan 12, 2015: Helomics Supports the Work of the UK's Personalised Healthcare Alliance 27

Corporate Communications 28

May 11, 2015: Helomics CEO Named to Pennsylvania Bio Board of Directors 28

Product News 29

Mar 15, 2016: Helomics Launches GeneFx Colon to Identify Patients with High Risk Stage II Colon Cancer 29

Feb 08, 2016: Helomics Launches CellFx, a Key Research Component of Their Precision Cellular Analytical Platform Further Expanding Their Comprehensive Tumor Profiling Offering to Patients, Physicians and Life Science Industry 30

Mar 12, 2015: Helomics to Present at the 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference in New York 31

Mar 11, 2015: Helomics, Prime Health Services Sign Contract to Expand Access to ChemoFx And Comprehensive Tumor Profiling 32

Mar 10, 2015: Helomics Awarded Unique CPT Codes-(Category I MAAA) for ChemoFx By American Medical Association 33

Other Significant Developments 34

Mar 26, 2015: Helomics Partners with Leading Global Healthcare Companies to Support The 100,000 Genomes Project 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Helomics Corporation , Medical Equipment, Deals by Type, 2010 to YTD 2016 1

Helomics Corporation , Medical Equipment, Deals By Year, 2010 to YTD 2016 1

Helomics Corporation , Medical Equipment, Deals By Region, 2010 to YTD 2016 1

Helomics Corporation , Medical Equipment, Deals By Market, 2010 to YTD 2016 1

Helomics Corporation , Medical Equipment, Deals By Year, 2010 to YTD 2016 6

Helomics Corporation , Medical Equipment, Deals by Type, 2010 to YTD 2016 7

Helomics Corporation , Medical Equipment, Deals By Region, 2010 to YTD 2016 8

Helomics Corporation , Medical Equipment, Deals by Market, 2010 to YTD 2016 9

List of Tables

Helomics Corporation , Medical Equipment, Key Facts 1

Helomics Corporation , Medical Equipment, Deals Summary, 2010 to YTD 2016 1

Helomics Corporation , Medical Equipment, Deals By Year, 2010 to YTD 2016 6

Helomics Corporation , Medical Equipment Deals By Type, 2010 to YTD 2016 7

Helomics Corporation , Medical Equipment, Deals By Region, 2010 to YTD 2016 8

Helomics Corporation , Deals By Market, 2010 to YTD 2016 9

Helomics Corporation , Medical Equipment, Deals Summary, 2010 to YTD 2016 10

Precision Therapeutics Raises US$14 Million In Venture Financing 11

Precision Therapeutics Secures US$35 Million In Series D Financing Round 12

Healthcare Royalty Invests USD60 Million in Precision Therapeutics 14

Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test 15

Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 17

Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics 19

Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 20

Rosetta Genomics Enters Into Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 21

Helomics Corporation , Key Competitors 23

Helomics Corporation , Key Employees 24

Helomics Corporation , Other Locations 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Helomics Corporation, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com